General Information of the Compound
Compound ID
CP0529924
Compound Name
US20230312582, Example Control
    Show/Hide
Synonyms
PMID28447479-Compound-2
Pyrido/pyrrolo-fused pyrimidine derivative 1
    Show/Hide
Structure
Formula
C21H23N7O2
Molecular Weight
405.462
Canonical SMILES
O=C(COCCc1cnn[nH]1)N1Cc2cnc(NC3Cc4ccccc4C3)nc2C1
    Show/Hide
InChI
InChI=1S/C21H23N7O2/c29-20(13-30-6-5-17-10-23-27-26-17)28-11-16-9-22-21(25-19(16)12-28)24-18-7-14-3-1-2-4-15(14)8-18/h1-4,9-10,18H,5-8,11-13H2,(H,22,24,25)(H,23,26,27)
    Show/Hide
InChIKey
ILOFWCAZDNILKY-UHFFFAOYSA-N
Physicochemical Property
logP
1.2755
Rotatable Bonds
7
Heavy Atom Count
30
Polar Areas
108.92
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 76285327
ChEMBL ID
CHEMBL4448598
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01786, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  1
1
IC50 < 1.7 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Pyrido/pyrrolo-fused pyrimidine derivative 1 )
Drug Name Pyrido/pyrrolo-fused pyrimidine derivative 1
Company ELI LILLY AND COMPANY
Indication
Pain
Patented
Target(s)
Extracellular lysophospholipase D (E-NPP2)
Inhibitor